| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.1M | -66.0% |
| R&D Expense | $32.8M | -69.8% |
| SG&A Expense | $26.5M | -4.5% |
| Operating Income | -$58.4M | +51.9% |
| Pre-tax Income | -$71.3M | +39.9% |
| Income Tax | -$398K | — |
| Net Income | -$70.9M | +40.2% |
| EPS (Basic) | -$15.53 | -609.1% |
| EPS (Diluted) | -$15.53 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.9M | -26.8% |
| Accounts Receivable | $407K | -85.3% |
| Inventory | $900K | -68.1% |
| Current Assets | $43.8M | -62.3% |
| Total Assets | $43.8M | -65.2% |
| Current Liabilities | $4.0M | -84.5% |
| Total Liabilities | $48.4M | -29.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.9M | +33.8% |
| Capital Expenditures | $1.0M | -56.0% |
| Investing Cash Flow | $48.7M | +12.1% |
| Financing Cash Flow | -$3.6M | -109.4% |
| Free Cash Flow | -$62.0M | +34.4% |
| -609.1% |
| Stockholders' Equity |
| -$4.6M |
| -108.0% |